MSI Financial Services’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.03M Sell
18,449
-1,567
-8% -$90.2K 0.03% 431
2016
Q3
$1.23M Sell
20,016
-15,133
-43% -$991K 0.04% 362
2016
Q2
$2.23M Sell
35,149
-6,706
-16% -$422K 0.08% 232
2016
Q1
$2.52M Sell
41,855
-26,822
-39% -$1.64M 0.11% 201
2015
Q4
$4.8M Buy
68,677
+29,086
+73% +$2.06M 0.22% 112
2015
Q3
$2.63M Sell
39,591
-1,712
-4% -$133K 0.21% 106
2015
Q2
$3.24M Sell
41,303
-36,204
-47% -$2.82M 0.23% 97
2015
Q1
$5.92M Buy
+77,507
New +$5.7M 0.41% 46
2014
Q4
Sell
-29,898
Closed -$1.9M 2745
2014
Q3
$1.9M Sell
29,898
-4,492
-13% -$277K 0.23% 114
2014
Q2
$2.1M Sell
34,390
-2,224
-6% -$129K 0.28% 85
2014
Q1
$2.07M Buy
36,614
+758
+2% +$43K 0.3% 81
2013
Q4
$1.92M Buy
35,856
+1,062
+3% +$53.1K 0.29% 86
2013
Q3
$1.6M Buy
34,794
+16,214
+87% +$740K 0.28% 89
2013
Q2
$785K Buy
+18,580
New +$773K 0.16% 161

Other funds holding PJP

MSI Financial Services's PJP Position: Q4 2016 in Review

MSI Financial Services reduced its Invesco Pharmaceuticals ETF (PJP) stake by 7.8% in Q4 2016, selling an estimated $90.2K and leaving 18,449 shares worth $1.03M. The position accounts for 0.03% of the portfolio, ranked #431.

MSI Financial Services first reported a position in PJP in Q2 2013 and has held it in 14 quarters since. The position peaked at $5.92M in Q1 2015. 101 funds tracked by Wall St. Rank hold PJP as of Q4 2016.

  • MSI Financial Services held 18,449 shares of Invesco Pharmaceuticals ETF worth $1.03M as of Q4 2016.
  • MSI Financial Services sold 1,567 Invesco Pharmaceuticals ETF shares in Q4 2016, an estimated $90.2K.
  • Invesco Pharmaceuticals ETF made up 0.03% of MSI Financial Services's portfolio in Q4 2016, its #431 holding.
  • MSI Financial Services first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and has held it in 14 quarters since.
  • MSI Financial Services's Invesco Pharmaceuticals ETF position peaked at $5.92M in Q1 2015.
  • 101 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.